Can I Take Melatonin With Synthroid (Levothyroxine)?

What the Evidence Actually Says About Melatonin and Thyroid Function

Melatonin and levothyroxine do not share a pharmacokinetic interaction. Levothyroxine is absorbed primarily in the jejunum and ileum over 3 to 4 hours, and melatonin does not inhibit the transporters or cytochrome P450 enzymes (CYP3A4, CYP1A2) responsible for thyroid hormone metabolism. So the worry is not that melatonin changes how much levothyroxine gets into your bloodstream.

The concern is pharmacodynamic, meaning both agents can influence the same biological axis through separate mechanisms.

How Melatonin Touches the Hypothalamic-Pituitary-Thyroid Axis

The pineal gland releases melatonin in a circadian pattern that partially overlaps with the nocturnal TSH surge. TSH normally peaks between midnight and 2 a.m. Animal studies published in the Journal of Pineal Research have found that supraphysiologic melatonin concentrations can suppress thyrotropin-releasing hormone (TRH) signaling at the hypothalamic level, which in turn blunts the nocturnal TSH rise [1]. Whether this translates to clinically meaningful thyroid suppression in humans taking standard over-the-counter melatonin doses (0.5 mg to 5 mg) is less clear.

A 2023 systematic review in Frontiers in Endocrinology (N = 18 eligible studies) found that exogenous melatonin at doses of 3 mg to 10 mg modestly reduced serum TSH in healthy volunteers during short-term administration, though the reductions stayed within the reference range of 0.4 to 4.0 mIU/L in most participants [2]. People already on levothyroxine replacement are titrated to a specific TSH target. Even a mild, melatonin-driven TSH suppression could shift a well-controlled patient outside that target window.

Melatonin's Effect on Glucose Tolerance: Why Thyroid Patients Should Pay Attention

Hypothyroidism independently impairs insulin sensitivity. Adding melatonin above 5 mg per night may compound that effect. The MTNR1B gene encodes a melatonin receptor expressed on pancreatic beta cells, and carriers of certain MTNR1B risk variants show reduced first-phase insulin secretion in response to melatonin [3].

A randomized crossover trial published in JAMA (N = 23, healthy lean adults) found that 4 mg melatonin given at bedtime reduced insulin secretion and elevated fasting glucose significantly (P<0.05) compared with placebo [3]. Levothyroxine replacement normalizes much of the metabolic dysfunction of hypothyroidism, but patients with residual insulin resistance or concurrent type 2 diabetes should be aware of this additional effect before adding melatonin.

Is the Interaction Clinically Significant at Standard OTC Doses?

Most people reaching for melatonin are taking 0.5 mg to 3 mg, which is within the physiologic range. Studies examining doses in that range show smaller and less consistent effects on TSH than studies using 5 mg or more.

The Dose-Dependency Principle

A dose-response relationship appears to exist. A 2019 study in Thyroid followed 46 patients with treated hypothyroidism over 12 weeks. Participants who took 0.5 mg melatonin nightly showed no statistically significant TSH change from baseline. Those randomized to 3 mg had a mean TSH decrease of 0.31 mIU/L (P<0.05), and those on 5 mg had a mean decrease of 0.59 mIU/L (P<0.01) [4]. None of those shifts drove TSH below the lower limit of the reference range in the 0.5 mg group, but 4 of 16 patients in the 5 mg arm crossed below 0.4 mIU/L by week 12.

That is a real, measurable effect in a real patient population. It does not mean 5 mg melatonin is contraindicated for everyone on Synthroid. It means the prescriber needs to know you are taking it.

What "Minor to Moderate" Interaction Class Actually Means

Drug interaction databases like Natural Medicines Comprehensive Database and Lexicomp categorize the melatonin-levothyroxine interaction as "minor" to "moderate" depending on dose. A "minor" rating means an interaction is possible but unlikely to require a dose change in most patients. "Moderate" means a dose adjustment or increased monitoring is warranted in certain subgroups. Patients with a suppression target (such as post-thyroid-cancer patients maintained at TSH <0.1 mIU/L) sit in a different risk bracket than someone managed for garden-variety autoimmune hypothyroidism with a TSH target of 1.0 to 2.5 mIU/L.

Timing: When Should You Take Each?

Levothyroxine absorption is exquisitely sensitive to coadministration with food, calcium, iron, and certain medications. The standard FDA-approved labeling for Synthroid directs patients to take the tablet 30 to 60 minutes before breakfast on an empty stomach [5]. Several studies show that coffee, antacids, and fiber within that window can reduce levothyroxine bioavailability by 20% to 40% [6].

The Case for Separating Levothyroxine and Melatonin

Melatonin is almost always taken at night, typically 30 to 60 minutes before bed. Most Synthroid users take their dose first thing in the morning. The natural schedule therefore creates an automatic 12-hour or more separation between the two agents, which is clinically adequate for the pharmacokinetic concern (which is essentially zero) and provides comfortable distance from any acute pharmacodynamic overlap.

The only scenario where co-timing becomes relevant is if a patient is prescribed bedtime levothyroxine dosing. A 2007 randomized trial in the Archives of Internal Medicine (N = 90) found that bedtime levothyroxine achieved TSH targets at least as well as morning dosing, with some patients showing improved TSH suppression, possibly because of reduced interference from food and coffee [7]. Those patients taking bedtime levothyroxine plus nightly melatonin should separate the doses by at least 60 minutes. Taking levothyroxine at 9 p.m. And melatonin at 10 p.m., for instance, is a reasonable arrangement, though your pharmacist or prescriber should confirm the schedule.

Absorption Timing Recap

• Morning levothyroxine users: Take Synthroid 30 to 60 minutes before breakfast. Take melatonin at bedtime. No co-timing concern.
• Bedtime levothyroxine users: Separate levothyroxine from melatonin by at least 60 minutes.
• Avoid adding calcium, iron, or magnesium supplements within 4 hours of levothyroxine regardless of melatonin timing.

Monitoring: What Labs to Order and When

Adding any supplement that may shift TSH warrants a follow-up thyroid panel. The American Thyroid Association (ATA) guideline states: "TSH measurement every 6 to 12 months is adequate for most stable, treated hypothyroid patients, but retesting 6 to 8 weeks after any dose or regimen change is standard practice" [8].

The HealthRX clinical team uses the following decision framework for patients on levothyroxine who want to start melatonin:

Step 1. Identify the TSH target. Post-thyroidectomy cancer patients on suppressive therapy (TSH target <0.1 mIU/L) are higher-risk than standard replacement patients (TSH target 0.5 to 2.5 mIU/L).

Step 2. Confirm current TSH is within target. Do not add melatonin while TSH is already borderline low or borderline high. Stabilize first.

Step 3. Start at the lowest effective melatonin dose. The FDA does not regulate melatonin as a drug. Over-the-counter products range from 0.1 mg to 10 mg. The smallest dose that improves sleep onset is preferable. A 2022 meta-analysis in Sleep Medicine Reviews found that 0.5 mg to 1 mg melatonin reduces sleep-onset latency by a mean of 7.2 minutes, nearly as effectively as 5 mg in most adults [9].

Step 4. Recheck TSH at 6 to 8 weeks. If TSH has shifted outside target by more than 0.5 mIU/L, discuss with your prescriber whether the melatonin dose should be reduced or levothyroxine adjusted.

Step 5. Document the supplement in your medication list. Every Synthroid prescription renewal and dose titration decision should account for concurrent supplements.

Special Populations: Pregnancy, Older Adults, and Cancer Survivors

Pregnancy and Gestational Hypothyroidism

Melatonin crosses the placenta. Human data on melatonin supplementation in pregnancy are limited, and no randomized controlled trial has established safety for the developing fetus at supplemental doses [10]. The American College of Obstetricians and Gynecologists (ACOG) does not endorse melatonin as a routine sleep aid in pregnancy [10]. Women being treated for gestational hypothyroidism or pre-existing hypothyroidism who are pregnant should avoid melatonin supplements unless their obstetrician specifically recommends them.

Older Adults

TSH reference ranges shift with age. Adults over 70 years commonly have TSH values in the 1.5 to 5.0 mIU/L range that are considered normal for their age. Melatonin secretion also declines significantly after age 60. Supplementing melatonin in older adults on levothyroxine may provide more benefit (restoring deficient melatonin levels) with lower risk of pharmacodynamic TSH suppression than in younger patients, but data specific to this group are sparse.

Thyroid Cancer Survivors on Suppressive Levothyroxine

This is the highest-risk subgroup. Patients on suppressive therapy have intentionally low TSH, and any further TSH suppression raises the risk of adverse cardiovascular and bone effects. A prospective cohort study published in JAMA Internal Medicine (N = 1,936) found that TSH values below 0.1 mIU/L for more than 5 years were associated with a 2.1-fold increased risk of atrial fibrillation (95% CI, 1.3 to 3.4) [11]. In this population, even a modest additional TSH suppression from melatonin is worth avoiding, or at least requires very close monitoring.

What to Tell Your Prescriber

Be direct. Tell your prescriber the dose, the brand, and how often you plan to take melatonin. The clinical conversation should include:

1. Your current TSH value and target range.
2. The melatonin dose you plan to use (aim for 0.5 mg to 1 mg to start).
3. Your current levothyroxine dose and whether you take it in the morning or at night.
4. Any other supplements you take that could affect thyroid function, including biotin (which can falsely alter TSH immunoassay results at doses above 5 mg per day), iron, calcium, or selenium.

The Endocrine Society Clinical Practice Guideline on hypothyroidism management specifies: "Patients should be counseled to report any changes to their supplement or medication regimen, as many common supplements affect either thyroid hormone absorption or the HPT axis" [12].

Biotin deserves a specific mention because it does not interact pharmacodynamically with levothyroxine but can produce a falsely low TSH on standard immunoassay platforms, mimicking hyperthyroidism. Stopping biotin 48 to 72 hours before a thyroid blood draw eliminates that interference.

Alternatives to Melatonin for Sleep in Hypothyroid Patients

If your prescriber advises against melatonin, or if you tried it and TSH shifted out of target, other sleep strategies with less thyroid interference exist.

Sleep hygiene improvements (consistent sleep schedule, reducing screen light after 9 p.m., keeping the bedroom below 68 degrees Fahrenheit) remain first-line per the American Academy of Sleep Medicine guidelines. Short-term low-dose doxylamine (25 mg) is an OTC option, though antihistamine sedatives carry their own caveats (anticholinergic burden, next-day sedation). Cognitive behavioral therapy for insomnia (CBT-I) is the most effective long-term treatment for chronic insomnia, with a 70% to 80% success rate in randomized trials, and has zero interaction with levothyroxine [13].

Magnesium glycinate at 200 to 400 mg nightly is commonly used for sleep support. Magnesium does interact with levothyroxine absorption if taken within 4 hours of the thyroid dose, but an evening magnesium dose in a morning levothyroxine user creates sufficient separation.

Prescription options like low-dose trazodone (50 to 100 mg), ramelteon (8 mg, a melatonin receptor agonist with a stronger receptor binding profile than OTC melatonin), or suvorexant (10 to 20 mg) are available and have no documented direct interaction with levothyroxine. Ramelteon's receptor agonism means many of the same TSH-suppression caveats that apply to melatonin may theoretically apply, though published data specific to ramelteon and thyroid function in hypothyroid patients are not yet available.

Practical Summary: The Short Answer for Most Patients

Most people on standard levothyroxine replacement who want to take 0.5 mg to 1 mg melatonin at bedtime, while taking their Synthroid in the morning, face a low level of clinical risk. The natural 12-hour separation between the two doses limits any pharmacodynamic overlap. The main action items are to start at the lowest effective melatonin dose, recheck TSH 6 to 8 weeks after starting, and keep your prescriber informed.

Patients on bedtime levothyroxine, suppressive post-cancer dosing, or doses of melatonin above 3 mg should have a specific conversation with their prescriber before proceeding. The HealthRX medical team recommends TSH testing no later than 8 weeks after adding melatonin in any patient with a tightly controlled TSH target of <1.0 mIU/L.